BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36004346)

  • 21. The evolution in the use of MIBG scintigraphy in pheochromocytomas and paragangliomas.
    Rufini V; Treglia G; Perotti G; Giordano A
    Hormones (Athens); 2013; 12(1):58-68. PubMed ID: 23624132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.
    Rao JU; Engelke UF; Rodenburg RJ; Wevers RA; Pacak K; Eisenhofer G; Qin N; Kusters B; Goudswaard AG; Lenders JW; Hermus AR; Mensenkamp AR; Kunst HP; Sweep FC; Timmers HJ
    Clin Cancer Res; 2013 Jul; 19(14):3787-95. PubMed ID: 23723300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
    Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K
    J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catecholamine-induced cardiomyopathy improvement after para-aortic paraganglioma resection: a case report.
    Ranjbar M; Amin A; Totonchi Z; Ghaemmaghami Z; Jalilian Z; Hesami M; Givtaj N; Jadbabaei AN; Divanbeigi I; Mazloomfard MM
    ESC Heart Fail; 2022 Feb; 9(1):213-218. PubMed ID: 34967117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open-label, single-arm, multi-center, phase II clinical trial of single-dose [
    Inaki A; Shiga T; Tsushima Y; Jinguji M; Wakabayashi H; Kayano D; Akatani N; Yamase T; Kunita Y; Watanabe S; Hiromasa T; Mori H; Hirata K; Watanabe S; Higuchi T; Tomonaga H; Kinuya S
    Ann Nucl Med; 2022 Mar; 36(3):267-278. PubMed ID: 34870794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma.
    Zhang X; Wakabayashi H; Hiromasa T; Kayano D; Kinuya S
    Semin Nucl Med; 2023 Jul; 53(4):503-516. PubMed ID: 36641337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.
    Maurice JB; Troke R; Win Z; Ramachandran R; Al-Nahhas A; Naji M; Dhillo W; Meeran K; Goldstone AP; Martin NM; Todd JF; Palazzo F; Tan T
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1266-70. PubMed ID: 22526961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas.
    van Houtum WH; Corssmit EP; Douwes Dekker PB; Jansen JC; van der Mey AG; Bröcker-Vriends AH; Taschner PE; Losekoot M; Frölich M; Stokkel MP; Cornelisse CJ; Romijn JA
    Eur J Endocrinol; 2005 Jan; 152(1):87-94. PubMed ID: 15762191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison.
    Maurea S; Cuocolo A; Reynolds JC; Neumann RD; Salvatore M
    Q J Nucl Med; 1996 Dec; 40(4):365-71. PubMed ID: 9050342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extra-adrenal pheochromocytoma in the organ of Zuckerkandl: diagnosis and treatment strategies.
    Kahraman D; Goretzki PE; Szangolies M; Schade H; Schmidt M; Kobe C
    Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):436-9. PubMed ID: 21374546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
    Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
    J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paragangliomas: clinical overview.
    Young WF
    Ann N Y Acad Sci; 2006 Aug; 1073():21-9. PubMed ID: 17102068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SDHB large deletions are associated with absence of MIBG uptake in metastatic lesions of malignant paragangliomas.
    Petenuci J; Fagundes GFC; Benedetti AFF; Guimaraes AG; Afonso ACF; Mota FT; Magalhães ALF; Coura-Filho GB; Zerbini MCN; Siqueira S; Montenegro FLM; Srougi V; Tanno FY; Chambo JL; Ferrari MSS; Bezerra Neto JE; Pereira MAA; Latronico AC; Fragoso MCBV; Mendonca BB; Hoff AO; Almeida MQ
    Endocrine; 2021 May; 72(2):586-590. PubMed ID: 33420946
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction.
    Defeudis G; Fioriti E; Palermo A; Tuccinardi D; Minucci A; Capoluongo E; Pozzilli P; Manfrini S
    Hormones (Athens); 2018 Jun; 17(2):279-284. PubMed ID: 29860716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial.
    Wiseman GA; Pacak K; O'Dorisio MS; Neumann DR; Waxman AD; Mankoff DA; Heiba SI; Serafini AN; Tumeh SS; Khutoryansky N; Jacobson AF
    J Nucl Med; 2009 Sep; 50(9):1448-54. PubMed ID: 19690028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.
    Quint LE; Glazer GM; Francis IR; Shapiro B; Chenevert TL
    Radiology; 1987 Oct; 165(1):89-93. PubMed ID: 3628794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
    Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
    J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG PET in the evaluation of phaeochromocytoma: a correlative study with MIBG scintigraphy and Ki-67 proliferative index.
    Lin M; Wong V; Yap J; Jin R; Leong P; Campbell P
    Clin Imaging; 2013; 37(6):1084-8. PubMed ID: 24035263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant Paraganglioma Complicated With Catecholamine Crisis and Catecholamine Cardiomyopathy: A Case Report and Review of the Literature.
    Ma X; Chen Z; Xia P; Zhang C; Yan K; Fan Y; Wang Y; Ti Y; Bu P
    Front Endocrinol (Lausanne); 2021; 12():790080. PubMed ID: 35185782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of 131I-MIBG, 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT scans in a patient with extra adrenal paraganglioma associated with SDH-B gene mutation.
    Kasaliwal R; Malhotra G; Lila A; Bandgar T; Shah NS
    Clin Nucl Med; 2015 May; 40(5):439-41. PubMed ID: 25742231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.